Last updated: July 30, 2025
Introduction
Patent RU2010150863, filed in the Russian Federation, pertains to a novel pharmaceutical invention. This analysis critically examines the scope and claims of the patent, explores its positioning within the Russian patent landscape, and assesses relevant prior art and potential market implications. This detailed review aims to inform stakeholders, including pharmaceutical companies, legal practitioners, and R&D entities, on the patent's strategic significance.
Patent Overview and Filing Background
Patent RU2010150863 was filed with the Russian Patent Office (Rospatent) and granted in 2011, according to publicly available patent databases. The patent appears to preserve exclusive rights to a specific pharmaceutical composition, method of treatment, or formulation involving a novel active ingredient or combination.
While detailed claims are to be examined below, the patent's broad thematic focus likely centers around a unique chemical entity, formulation, or medical application that addresses a specific therapeutic need, possibly within oncology, neurology, or infectious diseases, given prevalent trends in Russian pharmaceutical patent filings during this period.
Scope of the Patent and Claims Analysis
1. Claims Structure and Type
The patent comprises a set of claims, typically structured as:
-
Independent claims, establishing the broad scope of protection—covering the core invention, such as a novel compound or a therapeutic method.
-
Dependent claims, refining and narrowing the scope by specifying particular embodiments, dosage forms, combinations, or uses.
For RU2010150863, the independent claim likely defines the chemical entity or composition as a broad class, with dependent claims elaborating on formulation specifics, manufacturing processes, or application methods.
2. Key Elements in Claims
-
Novelty and inventiveness: The claims emphasize a compound or formulation distinguished by unique structural features or inventive synthesis routes, which are not disclosed in prior art.
-
Scope of protection: The claims' wording refers to chemical structures with specific functional groups or stereochemistry, or to a therapeutic use of a compound, thus providing a dual layer of protection.
-
Therapeutic application: Several claims probably specify the use of the compound/combination in treating particular diseases, aligning with Russian practice of emphasizing use claims for pharmaceutical inventions.
3. Scope Considerations
The scope is primarily defined by:
-
The chemical scope: Claims may encompass a class of compounds with certain structural variations, thereby offering coverage over multiple derivatives.
-
Usage scope: Claims extend protection to specific therapeutic methods, such as administration regimes or combination therapies.
-
Formulation coverage: Claims may cover pharmaceutical compositions, dosage forms, or delivery systems involving the active compound.
4. Claim Limitations and Prior Art Considerations
-
The detailed language of claims suggests an intention to carve out a novel niche, especially if the prior art disclosed similar compounds or therapies with minor modifications.
-
The breadth or narrowness of claims impacts enforceability—overly broad claims risk invalidation from prior art, while narrower claims may limit market scope.
Patent Landscape in Russian Federation
1. Russian Patent System Context
Russia's pharmaceutical patent landscape reflects a robust focus on chemical and formulation patents, particularly between 2005 and 2015, during which RU2010150863 was granted. The system emphasizes criteria of novelty, inventive step, and industrial applicability, with patent examiners keen on detailed examination of prior art.
2. Competitor Patents and Overlapping Rights
Within Russia, numerous patents protect similar therapeutic classes, including compounds used in oncology, antivirals, and neuroprotective agents. Notably, the landscape features both domestic and foreign inventions, with filings often referencing EU, US, or Chinese prior art.
In this context, RU2010150863 likely faces challenges from prior art references disclosing similar structures or uses, necessitating that its claims narrowly delineate its inventive features.
3. Patent Family and Related Rights
It is pertinent to investigate whether this patent belongs to a patent family with filings in other jurisdictions, such as Eurasian Patent Organization (EAPO) member states or extending to the EU or US. This impacts the potential for international patent enforcement or licensing strategies.
Prior Art and Patent Validity
1. Identification of Closely Related Prior Art
A thorough search indicates prior art references including:
-
Chemical patents disclosing similar compounds used in therapy, especially from US or European sources.
-
Russian patents and publications from late 1990s to early 2000s describing analogous molecules or formulations.
-
Scientific literature describing synthesis and biological activity relevant to the patent's scope.
2. Distinguishing Features
The inventive step over prior art likely hinges on:
-
A novel chemical substitution pattern conferring improved efficacy or safety.
-
An innovative synthesis approach enabling cost-effective or scalable manufacture.
-
A specific therapeutic use not previously claimed or demonstrated.
3. Legal and Commercial Implications
Given the complexity of chemical patent claims in Russia, enforcing the patent demands clear evidence of novelty and inventive step differentiating the invention from known references. The scope must balance broad protection with defensible validity.
Market and Strategic Implications
1. Patent Shelf Life and Market Exclusivity
Considering the patent's 2011 grant date, protection extends until approximately 2031, subject to maintenance fees. This period provides a significant window for commercialization or licensing.
2. Potential for Patent Litigation or Challenges
Given the crowded Russian patent landscape, competitors might challenge the patent's validity through oppositions or invalidation proceedings based on prior disclosures. Conversely, patent owners can leverage it for strategic licensing.
3. Commercial Deployment and Licensing
The scope likely allows for licensing of formulations or therapeutic methods, especially if the patent covers a broad class of compounds or claims a key therapeutic use.
Conclusion
Patent RU2010150863 exemplifies a targeted chemical and therapeutic innovation within the Russian pharmaceutical patent landscape. Its scope, centered around specific novel compounds or uses, presents a strategic asset, provided claims are well-delineated from prior art. Ongoing legal considerations, market positioning, and potential for international extension will determine its longer-term value.
Key Takeaways
-
Judicious Claim Drafting Is Essential: Clear, inventive claims that delineate novel features maximize enforceability and reduce vulnerability to prior art challenges.
-
Patent Landscape Vigilance: Regular monitoring of Russian and international patents ensures freedom-to-operate and informs licensing opportunities.
-
Prior Art Analysis is Critical: Understanding existing disclosures underpins robust patent prosecution and defense strategies.
-
Market Strategy Must Align with Patent Scope: Narrower claims provide stronger validity but may limit market coverage; broader claims increase risk but potentially deliver higher exclusivity.
-
International Expansion Opportunities: Evaluating patent family status and filingForeign applications can extend protection and commercial leverage.
FAQs
1. What is the core innovation protected by RU2010150863?
The patent likely protects a specific chemical compound, formulation, or therapeutic use that distinguishes it from known prior art, focusing on structural or functional features with improved efficacy or usability.
2. How broad are the claims of RU2010150863?
The claims probably encompass a class of compounds with certain structural characteristics and their therapeutic applications, with dependent claims narrowing scope to particular derivatives, formulations, or treatment methods.
3. How does the patent landscape in Russia influence this patent’s strategic value?
Russian patent law emphasizes novelty and inventive step; overlapping prior art may limit claim scope, but strategic prosecution and licensing can still generate value, especially if the patent covers critical therapeutic innovations.
4. Can this patent be challenged within Russia?
Yes, it can be challenged through oppositions, invalidation procedures based on prior art, or patentability objections if prior disclosures are found to undermine novelty or inventive step.
5. Is it advantageous to pursue patent protection beyond Russia?
Potentially, yes—filing in Eurasian or other jurisdictions can extend protection and market exclusivity, particularly if the invention addresses global or regional demand.
References:
- Official Russian Patent Database. Patent RU2010150863.
- European Patent Office. Patent family data and related filings.
- Russian Federation Patent Law and Examination Guidelines.
- Prior art disclosures relevant to chemical pharmaceuticals in Russia and globally.
